CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −16,960 | $13.79 | $234K | 431,950 |
| 2026-04-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,100 | $14.44 | $30K | 429,850 |
| 2026-04-09 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 22,831 | ||
| 2026-04-08 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −10,000 | $14.85 | $149K | 1,512,058 |
| 2026-04-08 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +2,344 | $3.99 | $9K | 293,718 |
| 2026-04-08 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −22,564 | $15.07 | $340K | 271,154 |
| 2026-04-08 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,344 | 88,297 | ||
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 453,248 |
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 465,129 |
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −30,841 | $14.83 | $457K | 434,288 |
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −100 | $15.48 | $2K | 434,188 |
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 37,553 | ||
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 391,658 | ||
| 2026-04-08 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −37,263 | $15.19 | $566K | 2,180,518 |
| 2026-04-07 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 457,586 |
| 2026-04-07 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.56 | $258K | 438,526 |
| 2026-04-07 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 52,275 | ||
| 2026-04-06 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 461,924 |
| 2026-04-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.33 | $273K | 442,864 |
| 2026-04-06 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 66,997 |
Page 14 of 119 · 2,375 trades